A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

NCT02927067 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

553

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus (CMV)

Interventions

DRUG: Maribavir
DRUG: Valganciclovir
OTHER: Placebo

Sponsor

Shire

Collaborators

[object Object]